deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02129647

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase II Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Sponsor: NYU Langone Health

Conditions Neurofibromatosis Type 2 Vestibular Schwannomas
Interventions Axitinib
Updated 13 times since 2017 Last updated: Nov 24, 2021 Started: Apr 30, 2014 Primary completion: Feb 5, 2019 Completion: Feb 5, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neurofibromatosis Type 2 and Vestibular Schwannomas, this trial is completed. The trial is conducted by NYU Langone Health and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Jan 2022 · 7 months · monthly snapshot~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2021 — Jan 2022 [monthly]

    Completed PHASE2

  5. Mar 2021 — Jun 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 8 earlier versions

  1. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2019 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  3. Jun 2019 — Sep 2019 [monthly]

    Active Not Recruiting PHASE2

  4. Mar 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  7. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NYU Langone Health
Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations